Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 6Frailty 4Lymphoma 3Prostatic Neoplasms 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Prostate Cancer Cured 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lung Neoplasms 1HER2 Positive Breast Carcinoma 1Colorectal Neoplasms 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Geriatric Assessment × Clear all
NCT06125145 2025-12-05

GAP

University of California, Davis

Phase NA Completed
30 enrolled
BreastGastrointestinalGenitourinary

Frailty, Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT03007641 2020-03-02

Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient

Fox Chase Cancer Center

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡